Interested in stem cell developments.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
rocky, what would get you to go long and what do you think is the best case scenario for ACTC?
Thanks, rocky. That did work and now I see what you mean. Please post if you track down anymore about this and I will do likewise. Thanks very much.
rocky, thanks for the reply but my problem was that I did go to that page previously as you suggested but when I do it while I do get the Court's Public Access Website with many options my page shows nothing even close to "Register of Actions."
I have tried all of the several options I see but none of them seems to get me to the document you are referring to. For some reason I must be coming up with a somewhat different Webpage than you get. Do you know of any other way for me to get to the document you are citing?
rocky301
Re: "Page 3, Item 10 makes me ill. I am not done finding out what went on here and why."
Which document are you referring to here? TIA
Great find, ricardo.
power_
Why and how are you guaranteeing increase in O/S?
janice, are you implying you are able to get the Slumbering Esquire's Club to do any thing in the case of certain obligations not being met by a company because as far as I can see they do zip, nada, nothing, unless presented with a bullet riddled already dead body, and, even then, only maybe.
You are right here on Investor HUb just go and check the 38 mil at the close, all sells.
jever000! you can feel it too..............
Matt, what has Gabriel done that Dick Hall hasn't already done?
I am a long time investor in DNAP but remain somewhat surprised at the constant pressure to push this thread towards being a squad of cheerleaders. What is the source of this need?
Arch, better check this
November 14, 2003
Biofrontera Pharmaceuticals and Kiadis BV discontinue merger talks
BOSTON GLOBE
Should medicine be colorblind?
Debate erupts over a drug that works better in African-Americans
By Carolyn Johnson, Globe Correspondent / August 24, 2004
A heart failure drug shown effective in African-Americans stands to become the first ethnically targeted drug, if a Lexington biotechnology firm is successful in its bid for federal approval.
It would be the first drug targeted at patients on the basis of ancestry -- a dangerous precedent, some ethicists and activists say, because a new marriage of race and genetics could distract from the real causes of disease.
The tricky part of this emerging debate is that the drug, BiDil, seems to work, extending the lives of African-Americans who sustain heart failure. The latest trial of BiDil was halted last month by an outside panel that decided the drug was so effective it was unconscionable to let some patients continue to get a placebo instead of BiDil. An earlier trial found the drug was of relatively little benefit to white patients.
So, if the government doesn't approve BiDil, it would deny African-Americans treatment for a disease that strikes them earlier than whites, often with a deadly outcome; if it does approve it, some will accuse the government of racism and bad science.
''I think if people get one little inkling that there's a biological basis to race, we could potentially lose ground into understanding racial difference in disease," said JudyAnn Bigby, director of the Office for Women, Family and Community Programs at Brigham and Women's Hospital.
......Continued at:
http://www.boston.com/news/globe/health_science/articles/2004/08/24/should_medicine_be_colorblind/
What seems of interest here is that DNAP might have or be able to generate personalized medicine diagnostic algorithms that would resolve any such racial issue by being, in fact, even more accurate and more precisely based on genetic factors. For instance, while DeBil generally works better on African-Americans than on whites, it seems very likely that there are also some whites that it also works very well for and some African-Americans that it does not work so well for, etc., thus a DNAP type more precise, genetically based, personalized medicine approach would dismiss any such racial issues as well as be more effective.
Grateful, I fear you have forgotten or don't know how much Crick and Watson stole from Roslind Franklin.
Are you sure it isn't David Faux Pas?
If it's not, sound the cardio alert for TTox.
Manti, Re:
"Lajolla shorts the heck out of this, and before they can convert to cover, dnap lands a big fish and puts the squeeze on them... now that would be sweeeeet.... we'd overshoot the moon. lol"
This occurred to me as a possibility, as well, for avoiding the usual debenture fiasco. Of course, it assumes (and I guess we will soon find out) that DNAP does now have a solid management team in place, one which has built in prevention of a debenture fiasco or knows how to take advantage of any attempt to launch one. It would also help if Lajolla is also convinced that DNAP management knows what they are doing. Another need for DNAP success is that the DNAP team is also not in cahoots with Lajolla and themselves ready to take advantage of a debenture fiasco. To repeat, we will find out soon enough.
Arch, I am not sure what point you are making here. You actually have me more worried. Check the squm.ob chart since that date. It does not inspire confidence.
http://finance.yahoo.com/q/bc?s=squm.ob&d=c
Godfrey, my opinion is that people who would, for instance, want to live forever have not really thought it out. After a billion years or so it could get pretty boring. In fact, we have to wonder about any god who could have sat around watching the past 15 billion years of evolution! At the end is he going to write a review or something?
ifida, do you also, as I do, see Senecio playing a big role in this area?
er1 and retro, I posted this about Senecio awhile back but I think both of you had left the board that evening and may have missed it, so I am posting it again since we seem to agree there is more than a minor connection here:
-----------------------------------------------
Retro, re your observation:
"If you remember the night I found the DNAprint logos in the image bin, I said it was obvious to me the same company developed or was maintaining the companies' websites. I now believe Senecio has something to do with all three (www.dnaphenomics.com; www.dnaprintasiapacific.com; and, www.DNAprint.com) companies' websites."
Further evidence for this is that from what I have found Senecio also owns the domain name
www.dnaphenomics.com
This is 2001 info.
W2P, Thanks. I stand corrected but not pleased that rather important changes which, with little effort, could have been made clear on the web site, have not been. It does seem like a reasonable expectation on the part of investors that this should be done on a current web site, even if a new site is in preparation, and especially given the apparent time lapse and import with respect to some of these events. It makes the official company website no more valuable than the Boards. But I can live with that and do feel a little chagrined since I should even expect it.
Beyond that, here are some questions that I would be interested reading responses to from you or anyone else:
Do you think the lack of clarity has been a matter of simple neglect, benign neglect, too many other things to do, or somewhere in the area minor to major subterfuge, or something else?
Also, what do you think will be the impact on the bottom line?
Further, what do you think will be the impact on investors who have taken pride in being part of a company which they judged to be doing the right things in the right way while trying to make major strides in improving the human condition, as well as benefiting their investors? Do you think such investors are asking too much?
W2P, when did Kondragunta submit a letter of resignation and if it wasn't in very recent days why is he still listed on the DNAP website?
*OT* I am long DNAP and intend to remain so yet I do think it is time to paraphrase one of the early tv ads:
It's delightful
It's delirious
It's deluxe
It's delimit
It's demarvelous
(and now)
It's DELETED!
Retro, re your observation:
"If you remember the night I found the DNAprint logos in the image bin, I said it was obvious to me the same company developed or was maintaining the companies' websites. I now believe Senecio has something to do with all three (www.dnaphenomics.com; www.dnaprintasiapacific.com; and, www.DNAprint.com) companies' websites."
Further eveidence for this is that from what I have found Senecio also owns the domain name
www.dnaphenomics.com
mingwan0, I like the things you have brought out and emphasized here and I do think a state of the art, worldwide telehealth system which will be highly efficient, comprehensive, and cost-effective in marketing and processing a fairly broad range of crucial genomic oriented services, is what DNAPrint and DNAPhenomics are aiming at and can achieve through integration with what Senecio refers to as it's "new data gathering systems for the personalization of medicine revolution."
Someone was asking about Luchese's deal awhile ago. Here it is:
On February 24, 2002, we entered into a Consulting Agreement and a Stock Purchase Option with Jack Luchese. At the time, Mr. Luchese was one of our directors. Under these agreements, and in addition to his service as one of our directors, Mr. Luchese has agreed to provide us substantial management, business
development and strategic planning advice through at least May 31, 2003. The parties may extend the agreement by mutual consent. The sole consideration that we must pay under the Consulting Agreement is the grant of options to purchase
stock under the Stock Purchase Option.
The Stock Purchase Option provides for the issuance of up to 28,000,000 shares of our stock to Mr. Luchese at an exercise price of $0.01 per share. Of these options, Mr. Luchese can earn options to purchase 1,680,000 shares by providing services as required by the Consulting Agreement, but without the
achievement of any particular performance milestones. Mr. Luchese only earns the remaining options by assisting us to achieve defined milestones, such as the sale or license of one of our products to a purchaser introduced to us by Mr.
Luchese. To the extent that any of the options become vested, they are exercisable by Mr. Luchese until February 23, 2012.
GE, I think you are right. stakkdek often speaks tongue in cheek when he is at his favorite hamburger place. I, myself, like to take my hamburgers with a few grains of salt.
Gcbr, do I need to remind you of this?:
By: elllk
14 Jul 2003, 09:24 AM EDT
Msg. 263787 of 269188
(This msg. is a reply to 263723 by DragonEsquire.)
Jump to msg. #
OT: Drag on Esq
I am glad you asked that question. Most humans don't notice. As you did notice, I am a member of another species. I am about average IQ for my species but I do have several points to make if I don't get shot first. One is that I do believe that the history of my species is considered to be rather dull by human standards since we have indulged in no wars, crusades, or other such endeavors and have developed no glitzy or deadly high tech weapons and not even movies, tv,or internet, which, in fact, may fall into a similar category, like alcohol, of slow suicide. Nor have we left a mark in the area of crime, certainly nothing that would provide even one episode for Court TV. I am basically waiting here for DNAP to discover that they have a gold mine still to tap in the veterinary sphere. The point can be made to you humans easily by citing or siting the wealthy race horse owners, though, in point of fact, that is the least of it. In the long run, I hope further means of communication with us and other species will be the outcome so that all the bashers and anti-bashers of the universe can learn to live in some kind of harmony without blowing the place up. Like most DNAPers, however, I am probably overly optimistic.
Gcbr, well interestingly we can understand the idiots, but the smart folks, especially if they are also rich, oppose even good change in the interest of conserving their money and hegemony which strangely leaves them participating in the execution of their own intelligence for a fuller feeling in the pocket that holds their wallet. Which is to say, they suffer from a form of myopia so severe they see little beyond themselves. In the case at hand, the myopic and wealthy smart are the Big Pharma who adhere to the general formulation and only absorb an outbreak if it threatens to get out of hand. Lets hope the DNAP outbreak, which scientifically does seem highly signicant, cannot be buried or picked apart piecemeal. Even if DNAP has to compromise in some form of absorption we will be rewarded immensely. But, to whit, there is still a possibility of the myopic smart making a misjudgment and DNAP becoming the MSFT of the genome. IBM, after all, did say to Bill Gates something like ...well that's ok you can sell the software to others, afterall the big money is in the hardware.
W2P, I would hope it is synergy and also that it is synergy still under the leadership of DNAP (which would leave us in a happy position).
Gcbr, I am all in favor of the bet of age and hope it turns out to be a reflection of commensurate wisdom (even if it is tongue in cheek, so to speak). On the other hand, you might qualify it with the two standard decimal deviation factor. After all Bucky made the best automobile ever, up to his time, but it never caught on even though it should have. And knowing that does worry me re great possible innovations of companies like DNAP.
stakddek,
I think I got your mane point and your observation on the benefits of hindsight. I assume most of the rest was tongue in cheek.
Stakkdek, are you pointing out that 95% of the predictions were at least two standard decimal errors above the target.
Niels, Should posters have something like a handicap rating based on their DNAP-2002-Challenge predictions?
DougS, I see only two posts by spook on IHUB (I assume only one post has been deleted). One was a comment on a post which was irrelevant to the case at hand and the other was clearly an attack at the IHUB board but they hardly establish what you referred to as a "modus operandi" on this board for spook. Further, your response here, to Phil, makes your decision to delete his post something of a mystery. Personally, I would not delete even the ad hominem attacks I have seen at times here (by both pro and con re DNAP), but if you are going to delete, I would think those are the first to deserve the hewing ax.
Gcbr, Phil's page also lists DNAP as one of his two favorite stocks.
W2P, Hope it clicks, it sounds like the ultimate in synergy to me.
chrisbaskett, I realize I jumped into another issue I was thinking about so to answer your question more precisely it seems clear to me that DNA Phenomics has not figured it out on their own and has some kind of relationship to DNAP evidenced, in part, by some of the DNAP content, including logo material, found on the DNA Phenomics website.